DOJ Hits Regeneron With False Claims Act Suit Over Eylea

By Craig Clough

The federal government has brought a False Claims Act intervenor complaint in Massachusetts against Regeneron, alleging the pharmaceutical giant fraudulently withheld information from its Medicare reports seeking reimbursement for its drug Eylea, the U.S. Department of Justice announced Wednesday. 

 Complaint attached | Read full article » | Save to favorites »